Cingulate CING
NASDAQ CING
$4.98 +0.32 (+6.87%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cingulate (CING) Revenue (2024 - 2026)

Updated

Analysis

Cingulate (CING) Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 25.40 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 16.99 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 15.03 Bn
10 Cingulate 69.20 Mn 14.20 Mn - -141,276.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -141,276.00
Jun 30, 2025 -138,761.00
Mar 31, 2025 -96,784.00
Jun 30, 2024 -3,497.00
Mar 31, 2024 -24,260.00
API Access

Cingulate Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CING&period=max&api_key=YOUR_API_KEY